IPP Bureau
Alembic receives USFDA final Approval for Desonide Cream
By IPP Bureau - December 12, 2022
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Lupin launches generic version of Pennsaid in the US
By IPP Bureau - December 12, 2022
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
Alembic receives EIR for oncology injectable formulation facility at Panelav
By IPP Bureau - December 12, 2022
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
By IPP Bureau - December 12, 2022
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
PM addresses valedictory function of 9th World Ayurveda Congress
By IPP Bureau - December 12, 2022
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
PM dedicates AIIMS Nagpur to the nation
By IPP Bureau - December 12, 2022
The hospital is being developed at a cost of more than Rs. 1,575 crore
National Health Ministers’ Conclave concludes in Varanasi
By IPP Bureau - December 12, 2022
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Progress under “PM Surakshit Matritva Abhiyan”
By IPP Bureau - December 12, 2022
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
Steps taken by Govt. to support diabetes patients
By IPP Bureau - December 12, 2022
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
PM lays foundation stone for National Institute for One Health in Nagpur
By IPP Bureau - December 12, 2022
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Entod Pharmaceuticals to launch GLO division
By IPP Bureau - December 12, 2022
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
GSK announces new global headquarters in central London
By IPP Bureau - December 12, 2022
Company to open new headquarters in 2024
Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
By IPP Bureau - December 12, 2022
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
By IPP Bureau - December 12, 2022
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData
By IPP Bureau - December 12, 2022
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
